在即將翻開新一頁學(xué)術(shù)篇章之際，我們誠摯邀請您一同回顧2023—2024年《中國胸心血管外科臨床雜志》胸外科重點文章。從專家共識、指南解讀，到研究前沿與熱點分析，從微創(chuàng)胸腔鏡術(shù)式的精妙改良，到復(fù)雜胸部腫瘤切除的策略創(chuàng)新，匯集了行業(yè)翹楚的智慧結(jié)晶。我們邀您共赴胸外科知識的巔峰盛宴，一同推動胸外科領(lǐng)域邁向新的輝煌！
孫藝琪, 徐翔宇, 孫飛, 單一波, 沈志明, 史宏燦. 剪切稀化型生物墨水在3D生物打印組織氣管中的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(12): 1859-1864. doi: 10.7507/1007-4848.202301039
SUN Yiqi, XU Xiangyu, SUN Fei, SHAN Yibo, SHEN Zhiming, SHI Hongcan.Research progress of shear-thinning bioink in 3D bioprinting tissue trachea.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(12):1859-1864. doi: 10.7507/1007-4848.202301039
劉治利, 張敏, 劉興元, 葛明建. 右上肺B2下移變異：一種特殊類型的氣管支氣管. 中國胸心血管外科臨床雜志, 2024, 31(12): 1759-1766. doi: 10.7507/1007-4848.202301012
LIU Zhili, ZHANG Min, LIU Xingyuan, GE Mingjian. Variation of rightB2 downwards-shift: A special type of tracheal bronchus. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(12): 1759-1766. doi:10.7507/1007-4848.202301012
王崢, 王猛, 孫大強. 新輔助免疫治療聯(lián)合化療后袖式切除術(shù)治療肺癌的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(12): 1775-1780. doi: 10.7507/1007-4848.202301033
WANG Zheng, WANG Meng, SUN Daqiang. Efficacy of sleeve lobectomyafter neoadjuvant chemoimmunotherapy in lung cancer: A retrospective cohortstudy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(12): 1775-1780. doi: 10.7507/1007-4848.202301033
曾偉強, 黨海麗, 茍云久. 微創(chuàng)肺段切除與肺葉切除治療ⅠA期非小細胞肺癌的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(12): 1838-1845. doi: 10.7507/1007-4848.202302026
ZENG Weiqiang, DANG Haili, GOU Yunjiu. Minimally invasivesegmentectomy versus lobectomy for stage ⅠA non-small cell lung cancer: A systematic review and meta-analysis.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(12):1838-1845. doi: 10.7507/1007-4848.202302026
吳漢然, 柳常青, 孫效輝, 田界勇, 梅新宇, 徐美青, 解明然. 新輔助免疫治療聯(lián)合微創(chuàng)McKeown術(shù)治療局部晚期食管鱗癌近期結(jié)果的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(12): 1767-1774. doi: 10.7507/1007-4848.202305038
WU Hanran, LIU Changqing, SUN Xiaohui, TIAN Jieyong, MEI Xinyu, XUMeiqing, XIE Mingran. Short-term outcomes of neoadjuvant immunotherapy combinedwith minimally invasive McKeown esophagectomy for locally advanced thoracicesophageal squamous cell carcinoma: A retrospective cohort study. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(12):1767-1774. doi: 10.7507/1007-4848.202305038
張繼朋, 周勇安, 趙晉波, 賈澄輝, 徐欣瑤, 向光宇, 李家賀, 盧強. 劍突下“三孔式”前縱隔胸腺疾病手術(shù)模塊化操作及標準流程技術(shù)要點—唐都經(jīng)驗. 中國胸心血管外科臨床雜志, 2024, 31(12): 1735-1742. doi: 10.7507/1007-4848.202305026
ZHANG Jipeng, ZHOU Yongan, ZHAO Jinbo, JIA Chenghui, XU Xinyao,XIANG Guangyu, LI Jiahe, LU Qiang. Technical points of modular operation andstandard procedure for three-port anterior mediastinal thymic disease surgeryvia subxiphoid approach: Experience of Tangdu Hospital. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(12): 1735-1742. doi:10.7507/1007-4848.202305026
田文鑫, 孫耀光, 吳青峻, 馬超, 焦鵬, 于瀚博, 黃川, 李東航, 田毅, 佟宏峰. COVID-19康復(fù)期患者行肺切除手術(shù)的安全性評價. 中國胸心血管外科臨床雜志, 2024, 31(12): 1753-1758. doi: 10.7507/1007-4848.202307052
TIAN Wenxin, SUN Yaoguang, WU Qingjun, MA Chao, JIAO Peng, YU Hanbo,HUANG Chuan, LI Donghang, TIAN Yi, TONG Hongfeng. Evaluation of perioperativesafety of lung surgery for patients with COVID-19. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(12): 1753-1758. doi:10.7507/1007-4848.202307052
嚴衛(wèi)亞, 王江南, 蔡健, 吳獻華, 丁學(xué)兵. 雙超細8F引流管應(yīng)用于單孔胸腔鏡肺葉/肺段切除術(shù)的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(12): 1788-1793. doi: 10.7507/1007-4848.202312030
YAN Weiya, WANG Jiangnan, CAI Jian, WU Xianhua, DING Xuebing.Application of dual ultrafine 8F drainage tubes in single-port thoracoscopiclobectomy/segmentectomy: A retrospective cohort study. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(12): 1788-1793. doi:10.7507/1007-4848.202312030
廖澤飛, 陳鳳玉, 林勇龍, 王榮華, 王耿杰, 張樂, 馬良赟. 胸腔鏡兩側(cè)肋間觀察孔肋弓下入路與經(jīng)典劍突下入路行前縱隔腫瘤切除療效比較的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(12): 1781-1787. doi: 10.7507/1007-4848.202402035
LIAO Zefei, CHEN Fengyu, LIN Yonglong, WANG Ronghua, WANG Gengjie,ZHANG Le, MA Liangyun. Clinical efficacy of anterior mediastinal tumorresection by thoracoscopic subcostal approach versus classic subxiphoidapproach: A retrospective cohort study. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2024, 31(12): 1781-1787. doi:10.7507/1007-4848.202402035
中國醫(yī)師協(xié)會胸外科醫(yī)師分會, 海峽兩岸醫(yī)藥衛(wèi)生交流協(xié)會胸外科專業(yè)委員會, 吳階平醫(yī)學(xué)基金會肺癌專業(yè)委員會, 浙江省醫(yī)師協(xié)會胸外科醫(yī)師分會, 福建省醫(yī)師協(xié)會胸外科醫(yī)師分會. 胸外科電子病歷質(zhì)量控制和管理中國專家共識（2024版）. 中國胸心血管外科臨床雜志, 2024, 31(12): 1703-1712. doi: 10.7507/1007-4848.202410041
Chinese Association of Thoracic Surgeons, Cross-Strait MedicineExchange Association’s Thoracic Surgery Professional Committee, WU JiepingMedical Foundation’s Lung Cancer Professional Committee, Zhejiang ProvincialThoracic Surgeons Associations, Fujian Provincial Thoracic SurgeonsAssociations. Chinese expert consensus on quality control and management ofelectronic medical records for thoracic surgery (version 2024). Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2024, 31(12): 1703-1712. doi:10.7507/1007-4848.202410041
王謙, 劉慧兵, 張魯昌, 靳德峰, 崔昭慶, 倪海洋, 魏育濤. 單孔充氣式縱隔鏡輔助經(jīng)裂孔食管切除術(shù)與功能性微創(chuàng)食管癌切除術(shù)治療食管癌的傾向性評分匹配研究. 中國胸心血管外科臨床雜志, 2024, 31(11): 1625-1631. doi: 10.7507/1007-4848.202210091
WANG Qian, LIU Huibing, ZHANG Luchang, JIN Defeng, CUI Zhaoqing, NIHaiyang, WEI Yutao. Single-port inflatable mediastinoscope-assisted transhiatalesophagectomy versus functional minimally invasive esophagectomy for esophagealcancer: A propensity score matching study. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2024, 31(11): 1625-1631. doi:10.7507/1007-4848.202210091
李丹, 姚曉軍. 食管癌合并HIV/AIDS的流行病學(xué)特征與診治進展. 中國胸心血管外科臨床雜志, 2024, 31(11): 1684-1689. doi: 10.7507/1007-4848.202301025
LI Dan, YAO Xiaojun. Epidemiological characteristics and progress indiagnosis and treatment of esophageal cancer with human immunodeficiencyvirus/acquired immune deficiency syndrome. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2024, 31(11): 1684-1689. doi:10.7507/1007-4848.202301025
江文洋, 汪巍, 江萬里, 王博, 蘇云術(shù), 丁祥超, 張興華, 康敢軍, 林慧慶, 耿慶. 肺移植患者術(shù)后血清cTnI變化的單中心回顧性研究. 中國胸心血管外科臨床雜志, 2024, 31(11): 1621-1624. doi: 10.7507/1007-4848.202304011
JIANG Wenyang, WANG Wei, JIANG Wanli, WANG Bo, SU Yunshu, DINGXiangchao, ZHANG Xinghua, KANG Ganjun, LIN Huiqing, GENG Qing. Changes of serumcTnI level in patients after lung transplantation: A retrospective study in asingle center. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(11): 1621-1624. doi: 10.7507/1007-4848.202304011
王泓懿, 李益行, 趙恒, 張言鵬, 高山, 王績釗, 趙軼龍, 李碩, 張廣健. 肺移植術(shù)后新型冠狀病毒感染四例. 中國胸心血管外科臨床雜志, 2024, 31(11): 1697-1702. doi: 10.7507/1007-4848.202306010
WANG Hongyi, LI Yixing, ZHAO Heng, ZHANG Yanpeng, GAO Shan, WANGJizhao, ZHAO Yilong, LI Shuo, ZHANG Guangjian. COVID-19 after lungtransplantation: Four case reports. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(11): 1697-1702. doi:10.7507/1007-4848.202306010
耿玉涵, 馬龍, 馬永明, 孫敬陽, 劉斌, 楊毅, 金剛, 朱自江. 單肺與雙肺移植治療終末期慢性阻塞性肺疾病的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(11): 1637-1644. doi: 10.7507/1007-4848.202305017
GENG Yuhan, MA Long, MA Yongming, SUN Jingyang, LIU Bin, YANG Yi,JIN Gang, ZHU Zijiang. Single versus bilateral lung transplantation forend-stage chronic obstructive pulmonary disease: A systematic review andmeta-analysis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(11): 1637-1644. doi: 10.7507/1007-4848.202305017
徐文正, 李志華, 潘相龍, 何志成, 許晶, 朱全, 吳衛(wèi)兵, 陳亮. 3D指導(dǎo)錐式肺段切除術(shù)治療肺實質(zhì)深部早期肺癌的腫瘤學(xué)療效研究. 中國胸心血管外科臨床雜志, 2024, 31(10): 1413-1421. doi: 10.7507/1007-4848.202212006
XU Wenzheng, LI Zhihua, PAN Xianglong, HE Zhicheng, XU Jing, ZHUQuan, WU Weibing, CHEN Liang. Oncological outcome of 3D-guided cone-shapedsegmentectomy for deep early-stage lung cancer. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(10): 1413-1421. doi:10.7507/1007-4848.202212006
曾偉強, 黨海麗, 茍云久. 經(jīng)劍突下與經(jīng)肋間入路胸腔鏡手術(shù)治療前縱隔腫瘤圍術(shù)期結(jié)果的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(10): 1514-1521. doi: 10.7507/1007-4848.202212074
ZENG Weiqiang, DANG Haili, GOU Yunjiu. Perioperative outcomes ofsubxiphoid versus intercostal thoracoscopic surgery for anterior mediastinaltumors: A systematic review and meta-analysis. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(10): 1514-1521. doi:10.7507/1007-4848.202212074
胡子豪, 宋佩東, 陳東來, 徐塑凱, 譚黎杰, 桑永華, 陳勇兵. 術(shù)后輔助治療對新輔助治療聯(lián)合手術(shù)切除食管鱗狀細胞癌患者預(yù)后影響的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(10): 1505-1513. doi: 10.7507/1007-4848.202212069
HU Zihao, SONG Peidong, CHEN Donglai, XU Sukai, TAN Lijie, SANGYonghua, CHEN Yongbing. Prognostic impact of adjuvant therapy on patients withesophageal squamous cell carcinoma receiving neoadjuvant therapy plusesophagectomy: A systematic review and meta-analysis. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(10): 1505-1513. doi:10.7507/1007-4848.202212069
張成龍, 王瑞堯, 肖闊, 陳軍. 吲哚菁綠熒光法與改良膨脹萎陷法應(yīng)用于胸腔鏡肺段切除術(shù)的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(10): 1486-1495. doi: 10.7507/1007-4848.202307001
ZHANG Chenglong, WANG Ruiyao, XIAO Kuo, CHEN Jun. Indocyanine greenfluorescence versus modified inflation-deflation method in thoracoscopicanatomic segmentectomy: A systematic review and meta-analysis. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2024, 31(10): 1486-1495. doi:10.7507/1007-4848.202307001
孫云剛, 張強, 莊宇, 王朝, 焦思楊, 姚夢旭, 邵豐. 優(yōu)先阻斷靶段肺靜脈吲哚菁綠熒光識別段間平面在胸腔鏡肺段切除術(shù)中的應(yīng)用. 中國胸心血管外科臨床雜志, 2024, 31(10): 1428-1433. doi: 10.7507/1007-4848.202307029
SUN Yungang, ZHANG Qiang, ZHUANG Yu, WANG Zhao, JIAO Siyang, YAOMengxu, SHAO Feng. Indocyanine green fluorescence identification of theintersegmental plane by preferentially ligating the target pulmonary veinduring thoracoscopic segmentectomy. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(10): 1428-1433. doi:10.7507/1007-4848.202307029
陳劍, 詹必成, 湯勇, 劉永志, 李根水, 劉建. 經(jīng)驗性與人工智能指導(dǎo)下精準肺段切除術(shù)效果比較的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(10): 1422-1427. doi: 10.7507/1007-4848.202310001
CHEN Jian, ZHAN Bicheng, TANG Yong, LIU Yongzhi, LI Genshui, LIUJian. Outcomes of empirical versus precise lung segmentectomy guided byartificial intelligence: A retrospective cohort study. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(10): 1422-1427. doi:10.7507/1007-4848.202310001
祁菲, 馮宏響, 朱偉杰, 石玉慧, 劉德若, 梁朝陽, 張真榕. 術(shù)前三維重建應(yīng)用于跨段肺結(jié)節(jié)切除的單中心回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(10): 1407-1412. doi: 10.7507/1007-4848.202312053
QI Fei, FENG Hongxiang, ZHU Weijie, SHI Yuhui, LIU Deruo, LIANGChaoyang, ZHANG Zhenrong. Application value of preoperative three-dimensionalreconstruction in the resection of lung nodules: A retrospective cohort studyin a single center. Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2024, 31(10): 1407-1412. doi: 10.7507/1007-4848.202312053
張斌, 鄭佳男, 陳亮, 朱全, 朱健, 聞偉. 直線切割縫合器牽引裝置在肺段切除術(shù)中離斷段支氣管的單中心回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(10): 1434-1441. doi: 10.7507/1007-4848.202312080
ZHANG Bin, ZHENG Jianan, CHEN Liang, ZHU Quan, ZHU Jian, WEN Wei.The benefits of stapler tractor dissociating segmental bronchus in lungsegmentectomy: A retrospective cohort study in a single center. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2024, 31(10): 1434-1441. doi:10.7507/1007-4848.202312080
闕昌浩, 王亞平, 葉智博, 李可勇, 金大成, 茍云久, 汪誠風. 胸腺瘤切除術(shù)后輔助放療療效的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(10): 1522-1530. doi: 10.7507/1007-4848.202312027
QUE Changhao, WANG Yaping, YE Zhibo, LI Keyong, JIN Dacheng, GOUYunjiu, WANG Chengfeng. Efficacy of adjuvant radiotherapy after thymomaresection: A systematic review and meta-analysis. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(10): 1522-1530. doi:10.7507/1007-4848.202312027
盧建國, 趙香梅, 甘紹印, 陳小放, 朱德奇, 閆二帥, 李小杰. 單孔胸腔鏡肺部手術(shù)應(yīng)用布比卡因脂質(zhì)體行肋間神經(jīng)阻滯鎮(zhèn)痛效果的前瞻性研究. 中國胸心血管外科臨床雜志, 2024, 31(10): 1442-1447. doi: 10.7507/1007-4848.202403051
LU Jianguo, ZHAO Xiangmei, GAN Shaoyin, CHEN Xiaofang, ZHU Deqi, YANErshuai, LI Xiaojie. Effectiveness of intercostal nerve block and analgesiawith bupivacaine liposomes in single-port thoracoscopic lung surgery: Aprospective study. Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2024, 31(10): 1442-1447. doi: 10.7507/1007-4848.202403051
張春莉, 牛鋼. 人工智能驅(qū)動的科學(xué)研究（AI4S）在藥物研發(fā)與臨床實踐中的應(yīng)用進展. 中國胸心血管外科臨床雜志, 2024, 31(10): 1392-1399. doi: 10.7507/1007-4848.202405020
ZHANG Chunli, NIU Gang. Progress of artificial intelligence forscience (AI4S) applications in drug development and clinical practice in thedigital age. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(10): 1392-1399. doi: 10.7507/1007-4848.202405020
張玉明, 劉懿賢, 鄭莉. 群體藥代動力學(xué)技術(shù)在虛擬臨床試驗中的應(yīng)用與發(fā)展趨勢. 中國胸心血管外科臨床雜志, 2024, 31(10): 1400-1406. doi: 10.7507/1007-4848.202405021
ZHANG Yuming, LIU Yixian, ZHENG Li. Application and developmenttrends of population pharmacokinetic techniques in virtual clinical trials.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(10):1400-1406. doi: 10.7507/1007-4848.202405021
張金龍, 林兆昊, 閔衛(wèi)潤, 曹煒, 李浩篪, 柏啟州, 董信春, 茍云久. 肺亞段與肺段切除術(shù)治療肺部小結(jié)節(jié)近期療效及安全性的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(10): 1496-1504. doi: 10.7507/1007-4848.202405042
ZHANG Jinlong, LIN Zhaohao, MIN Weirun, CAO Wei, LI Haochi, BAIQizhou, DONG Xinchun, GOU Yunjiu. Short-term efficacy and safety of pulmonarysubsegmentectomy versus segmentectomy in the treatment of patients with smallpulmonary nodules: A systematic review and meta-analysis. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(10): 1496-1504. doi:10.7507/1007-4848.202405042
涂秀華, 雷妹, 陳彥清, 林嶸嘉, 黃瑞珍, 項春梅. 預(yù)防性使用經(jīng)鼻高流量濕化氧療減少老年非小細胞肺癌患者術(shù)后肺部并發(fā)癥的傾向性評分匹配研究. 中國胸心血管外科臨床雜志, 2024, 31(9): 1274-1280. doi: 10.7507/1007-4848.202211083
TU Xiuhua, LEI Mei, CHEN Yanqing, LIN Rongjia, HUANG Ruizhen, XIANGChunmei. Prophylactic high-flow nasal cannula oxygen therapy can reducepostoperative pulmonary complications in elderly patients with non-small celllung cancer: A propensity score matching study. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(9): 1274-1280. doi:10.7507/1007-4848.202211083
楊思豪, 聶洪鑫, 孟輝. 急性肺損傷發(fā)病機制相關(guān)信號通路及其藥物干預(yù)的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(9): 1356-1362. doi: 10.7507/1007-4848.202211068
YANG Sihao, NIE Hongxin, MENG Hui. Research progress on signalpathways in pathogenesis of acute lung injury and the drug intervention.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(9):1356-1362. doi: 10.7507/1007-4848.202211068
張欣宇, 李林倩, 李浩然, 郭強, 閆紅麗, 李靖華, 程樹杰, 李鶴飛, 張珂, 楊季紅, 武建國. 計算機輔助設(shè)計修飾3D打印模型用于早期肺癌胸腔鏡亞肺葉切除術(shù)的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(9): 1266-1273. doi: 10.7507/1007-4848.202212033
ZHANG Xinyu, LI Linqian, LI Haoran, GUO Qiang, YAN Hongli, LIJinghua, CHENG Shujie, LI Hefei, ZHANG Ke, YANG Jihong, WU Jianguo. Applicationof computer-aided design modified 3D printing model in video-assistedthoracoscopic sublobular resection for early lung cancer: A retrospectivecohort study. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(9): 1266-1273. doi: 10.7507/1007-4848.202212033
劉寶東. 胸腔鏡肺段切除術(shù)段間界識別技術(shù)及生理機制研究進展. 中國胸心血管外科臨床雜志, 2024, 31(9): 1351-1355. doi: 10.7507/1007-4848.202212041
LIU Baodong. Research progress on identification of intersegmentalplane and its physiological mechanism in thoracoscopic segmentectomy. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(9):1351-1355. doi: 10.7507/1007-4848.202212041
王江南, 嚴衛(wèi)亞, 蔡健, 丁學(xué)兵. CT引導(dǎo)下Hook-wire精準定位孤立磨玻璃結(jié)節(jié)的危險因素及其Nomogram預(yù)測模型構(gòu)建. 中國胸心血管外科臨床雜志, 2024, 31(9): 1258-1265. doi: 10.7507/1007-4848.202212066
WANG Jiangnan, YAN Weiya, CAI Jian, DING Xuebing. Risk factors forCT-guided Hook-wire accurate localization of isolated ground-glass nodules andthe establishment of Nomogram prediction model. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(9): 1258-1265. doi:10.7507/1007-4848.202212066
馬鳳艷, 任娜, 田夢白, 劉燕. 肺癌患者手術(shù)治療決策參與和領(lǐng)悟社會支持的相關(guān)性分析. 中國胸心血管外科臨床雜志, 2024, 31(9): 1288-1293. doi: 10.7507/1007-4848.202302029
MA Fengyan, REN Na, TIAN Mengbai, LIU Yan. Correlation betweensurgery control preference and perceived social support of lung cancerpatients. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(9): 1288-1293. doi: 10.7507/1007-4848.202302029
顏秀岌, 張含露, 陳龍奇, 顧一敏, 王文憑. 單孔胸腔鏡后入路右肺中葉切除術(shù)52例前瞻性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(9): 1281-1287. doi: 10.7507/1007-4848.202310002
YAN Xiuji, ZHANG Hanlu, CHEN Longqi, GU Yimin, WANG Wenping.Uniportal thoracoscopic right middle lobectomy via posterior approach in 52patients: A prospective cohort study. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(9): 1281-1287. doi:10.7507/1007-4848.202310002
鐘?？?/span>, 李靖華, 林熙明, 方雪妮, 胡凱文, 周天. 深度學(xué)習(xí)在非小細胞肺癌預(yù)后模型中的應(yīng)用進展. 中國胸心血管外科臨床雜志, 2024, 31(9): 1345-1350. doi: 10.7507/1007-4848.202312004
ZHONG Ruikang, LI Jinghua, LIN Ximing, FANG Xueni, HU Kaiwen, ZHOUTian. Progress in the application of deep learning in prognostic models fornon-small cell lung cancer. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(9): 1345-1350. doi:10.7507/1007-4848.202312004
董懂, 張亞杰, 李鶴成. 2024年第2版《NCCN腫瘤臨床實踐指南—肺癌篩查》更新解讀. 中國胸心血管外科臨床雜志, 2024, 31(9): 1253-1257. doi: 10.7507/1007-4848.202407037
DONG Dong, ZHANG Yajie, LI Hecheng. Interpretation of the NCCNclinical practice guidelines in oncology: Lung cancer screening (version2.2024). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(9): 1253-1257. doi: 10.7507/1007-4848.202407037
江晨宇, 陳海泉, 鄧朝強. 《美國胸外科協(xié)會磨玻璃結(jié)節(jié)管理專家共識2023》解讀. 中國胸心血管外科臨床雜志, 2024, 31(9): 1249-1252. doi: 10.7507/1007-4848.202407073
JIANG Chenyu, CHEN Haiquan, DENG Chaoqiang. Interpretation of the2023 American Association for Thoracic Surgery (AATS) expert consensusdocument: Management of subsolid lung nodules. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(9): 1249-1252. doi:10.7507/1007-4848.202407073
張明輝, 隋洺驊, 邱甜甜, 孫雪, 譚曉, 侯代倫. 細支氣管腺瘤25例臨床及CT征象. 中國胸心血管外科臨床雜志, 2024, 31(8): 1127-1132. doi: 10.7507/1007-4848.202210048
ZHANG Minghui, SUI Minghua, QIU Tiantian, SUN Xue, TAN Xiao, HOUDailun. Clinical and CT findings of 25 patients with bronchiolar adenoma.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(8):1127-1132. doi: 10.7507/1007-4848.202210048
曾偉強, 黨海麗, 茍云久. 達芬奇機器人與電視胸腔鏡輔助手術(shù)治療縱隔腫瘤臨床效果比較的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(8): 1190-1197. doi: 10.7507/1007-4848.202210053
ZENG Weiqiang, DANG Haili, GOU Yunjiu. Clinical outcomes of Da-Vincirobot-assisted versus video-assisted thoracoscopic surgery for mediastinaltumors: A systematic review and meta-analysis. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(8): 1190-1197. doi:10.7507/1007-4848.202210053
任夢怡, 李瑾, 張明, 張淼, 高民, 陳偉. 心肺運動試驗在食管癌患者術(shù)后并發(fā)癥預(yù)測中應(yīng)用的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(8): 1148-1155. doi: 10.7507/1007-4848.202211060
REN Mengyi, LI Jin, ZHANG Ming, ZHANG Miao, GAO Min, CHEN Wei.Predictive value of cardiopulmonary exercise test in the postoperativecomplications in patients with esophageal cancer: A retrospective cohort study.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(8):1148-1155. doi: 10.7507/1007-4848.202211060
徐翔宇, 袁磊, 孫飛, 沈志明, 單一波, 盧毅, 朱劍煒, 陳文軒, 史宏燦. 納米顆粒應(yīng)用于非小細胞肺癌治療的研究熱點：文獻計量學(xué)方法分析. 中國胸心血管外科臨床雜志, 2024, 31(8): 1139-1147. doi: 10.7507/1007-4848.202212017
XU Xiangyu, YUAN Lei, SUN Fei, SHEN Zhiming, SHAN Yibo, LU Yi, ZHUJianwei, CHEN Wenxuan, SHI Hongcan. A bibliometric analysis of nanoparticles inthe treatment of non-small cell lung cancer. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(8): 1139-1147. doi:10.7507/1007-4848.202212017
孫振棟, 周一凡. 達芬奇機器人輔助胸腺擴大切除術(shù)治療重癥肌無力的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(8): 1215-1221. doi: 10.7507/1007-4848.202305048
SUN Zhendong, ZHOU Yifan. Research progress of da Vincirobot-assisted thoracoscopic extended thymectomy in the treatment of myastheniagravis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(8): 1215-1221. doi: 10.7507/1007-4848.202305048
李海天, 劉晴, 李斌, 陳玉珍, 孟于琪, 鄭智中, 惠一鳴. 新輔助PD-1/PD-L1抑制劑聯(lián)合化療治療可切除非小細胞肺癌有效性和安全性單組率的系統(tǒng)評價與 Meta 分析. 中國胸心血管外科臨床雜志, 2024, 31(8): 1198-1205. doi: 10.7507/1007-4848.202306029
LI Haitian, LIU Qing, LI Bin, CHEN Yuzhen, MENG Yuqi, ZHENGZhizhong, HUI Yiming. Effect and safety of PD-1/PD-L1 inhibitors combined withchemotherapy in the neoadjuvant therapy of resectable non-small cell lungcancer: A systematic review and meta-analysis of single-group rate. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(8):1198-1205. doi: 10.7507/1007-4848.202306029
任清林, 何文博, 岳佳瑞, 肖洪壁, 束余聲. 基于增強CT影像組學(xué)列線圖鑒別胸腺瘤風險程度的單中心回顧性研究. 中國胸心血管外科臨床雜志, 2024, 31(8): 1109-1118. doi: 10.7507/1007-4848.202308054
REN Qinglin, HE Wenbo, YUE Jiarui, XIAO Hongbi, SHU Yusheng.Contrast-enhanced CT-based radiomics nomogram for differentiation of low-riskand high-risk thymomas. Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2024, 31(8): 1109-1118. doi: 10.7507/1007-4848.202308054
盧高俊, 王若天, 劉寶東, 蘇雷, 錢坤, 張培龍, 趙騰, 張毅. 劍突下與肋間入路行胸腺擴大切除術(shù)治療重癥肌無力的單中心回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(8): 1119-1126. doi: 10.7507/1007-4848.202310071
LU Gaojun, WANG Ruotian, LIU Baodong, SU Lei, QIAN Kun, ZHANGPeilong, ZHAO Teng, ZHANG Yi. Extended thymectomy for myasthenia gravis viasubxiphoid versus intercostal approaches: A retrospective cohort study in asingle center. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(8): 1119-1126. doi: 10.7507/1007-4848.202310071
蔣斌誠, 許寧, 谷志濤, 方文濤. 非治療性胸腺切除術(shù)及胸腺切除對整體健康影響的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(8): 1222-1228. doi: 10.7507/1007-4848.202310046
JIANG Bincheng, XU Ning, GU Zhitao, FANG Wentao. Research progressof effect of non-therapeutic thymectomy and thymectomy on overall health.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(8):1222-1228. doi: 10.7507/1007-4848.202310046
應(yīng)金宏, 王鶯, 王秋香. 肺移植護理研究熱點及發(fā)展趨勢：基于CiteSpace的可視化分析. 中國胸心血管外科臨床雜志, 2024, 31(8): 1156-1163. doi: 10.7507/1007-4848.202402054
YING Jinhong, WANG Ying, WANG Qiuxiang. Visualization analysis ofhotspots and trends of lung transplantation nursing research based onCiteSpace. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(8): 1156-1163. doi: 10.7507/1007-4848.202402054
梁法清, 賀濤, 謝妍妍, 呂青. 保留乳頭的乳頭內(nèi)病變?nèi)楣茇喑鲂g(shù)用于乳腺癌保留乳房皮膚手術(shù)的前瞻性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(8): 1133-1138. doi: 10.7507/1007-4848.202406010
LIANG Faqing, HE Tao, XIE Yanyan, Lü Qing. Application ofmammary-duct exenteration of nipple-skin-sparing mastectomy for breast cancer:A prospective cohort study. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(8): 1133-1138. doi:10.7507/1007-4848.202406010
胡堅, 支修益, 劉倫旭, 中國醫(yī)藥教育協(xié)會肺癌醫(yī)學(xué)教育委員會, 吳階平醫(yī)學(xué)基金會肺癌專業(yè)委員會, 中國醫(yī)療保健國際交流促進會胸外科分會, 中國抗癌協(xié)會肺部腫瘤整合康復(fù)專業(yè)委員會, 浙江省醫(yī)師協(xié)會胸外科醫(yī)師分會, 浙江省預(yù)防醫(yī)學(xué)會肺癌預(yù)防與控制專業(yè)委員會. 直徑≤2 cm肺結(jié)節(jié)胸外科合理診療中國專家共識（2024）. 中國胸心血管外科臨床雜志, 2024, 31(8): 1077-1089. doi: 10.7507/1007-4848.202406056
HU Jian, ZHI Xiuyi, LIU Lunxu, Chinese Medical Education AssociationLung Cancer Medical Education Committee, Wu Jieping Medical Foundation LungCancer Professional Committee, Thoracic Surgery Branch of China Association forInternational Exchange of Medical Care, Chinese Anti-Cancer Association LungCancer Integrated Rehabilitation Professional Committee, Thoracic SurgeonsBranch of Zhejiang Medical Doctors Association, Zhejiang Preventive MedicineAssociation Lung Cancer Prevention and Control Special Committee. Chinesethoracic surgery expert consensus on rational diagnosis and treatment ofpulmonary nodules with a diameter≤2 cm (2024). Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2024, 31(8): 1077-1089. doi: 10.7507/1007-4848.202406056
黃俊俊, 孫久賀, 張士法, 劉洪鋒, 宋儒, 王謙, 陳立基, 蔡海波. 局部晚期可切除食管癌新輔助免疫治療進展. 中國胸心血管外科臨床雜志, 2024, 31(7): 1058-1065. doi: 10.7507/1007-4848.202211040
HUANG Junjun, SUN Jiuhe, ZHANG Shifa, LIU Hongfeng, SONG Ru, WANGQian, CHEN Liji, CAI Haibo. Progress of neoadjuvant immunotherapy in thetreatment of locally advanced resectable esophageal carcinoma. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2024, 31(7): 1058-1065. doi:10.7507/1007-4848.202211040
韓志偉, 岳鵬, 馬敏杰, 劉禮新, 胡文滕, 李瓊, 韓彪. 帶金屬支撐多側(cè)孔與普通超細引流管應(yīng)用于單孔胸腔鏡肺下葉切除術(shù)的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(7): 980-984. doi: 10.7507/1007-4848.202210045
HAN Zhiwei, YUE Peng, MA Minjie, LIU Lixin, HU Wenteng, LI Qiong,HAN Biao. The clinical application of metal supported multi-sided versusordinary ultra-fine drainage tube in the uniportal video-assisted thoracoscopiclower pulmonary lobectomy: A retrospective cohort study. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(7): 980-984. doi:10.7507/1007-4848.202210045
唐正能, 葛杰, 龔麗明, 王東坤, 邱浩. 快速現(xiàn)場評估聯(lián)合超聲支氣管鏡下穿刺診斷肺/縱隔病變的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(7): 1043-1049. doi: 10.7507/1007-4848.202211012
TANG Zhengneng, GE Jie, GONG Liming, WANG Dongkun, QIU Hao. Rapidon-site evaluation combined with endobronchial ultrasound for the diagnosis ofpulmonary/mediastinal lesions: A systematic review and meta-analysis. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(7):1043-1049. doi: 10.7507/1007-4848.202211012
高鑫, 王鑠鏈, 許帥, 馬文文, 徐子昂, 胡尕偉, 李慶新. 食管癌新輔助治療療效評價的網(wǎng)狀Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(7): 1035-1042. doi: 10.7507/1007-4848.202211041
GAO Xin, WANG Shuolian, XU Shuai, MA Wenwen, XU Ziang, HU Gawei, LIQingxin. The efficacy of neoadjuvant therapy for esophageal cancer: A networkmeta-analysis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(7): 1035-1042. doi: 10.7507/1007-4848.202211041
趙彥, 李輝, 谷麗, 游賓. 食管癌圍術(shù)期感染新型冠狀病毒一例. 中國胸心血管外科臨床雜志, 2024, 31(7): 1074-1076. doi: 10.7507/1007-4848.202301047
ZHAO Yan, LI Hui, GU Li, YOU Bin. Treatment of COVID-19 duringesophageal cancer surgery: A case report. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2024, 31(7): 1074-1076. doi:10.7507/1007-4848.202301047
冉興強, 施貴冬, 周瑜, 楊毫, 丁浩, 付茂勇. 不可切除食管鱗癌轉(zhuǎn)化手術(shù)的研究進展及前景. 中國胸心血管外科臨床雜志, 2024, 31(7): 1050-1057. doi: 10.7507/1007-4848.202305052
RAN Xingqiang, SHI Guidong, ZHOU Yu, YANG Hao, DING Hao, FU Maoyong.Advances and prospects of conversion surgery for unresectable esophagealsquamous cell carcinoma. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(7): 1050-1057. doi:10.7507/1007-4848.202305052
李可勇, 成濤, 金大成, 葉智博, 闕昌浩, 王亞平, 柏啟州. 充氣式縱隔鏡聯(lián)合腹腔鏡與微創(chuàng)經(jīng)胸食管切除術(shù)治療食管癌短期療效及安全性的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(7): 1027-1034. doi: 10.7507/1007-4848.202312050
LI Keyong, CHENG Tao, JIN Dacheng, YE Zhibo, QUE Changhao, WANGYaping, BAI Qizhou. Short-term efficacy and safety of inflatable video-assistedmediastinoscopic transhiatal esophagectomy and minimally invasive transthoracicesophagectomy for esophageal cancer: A systematic review and meta-analysis.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(7):1027-1034. doi: 10.7507/1007-4848.202312050
涂遠榮, 杜泉, 陳劍鋒, 林敏, 馮志. 胸腔鏡下擴大胸交感神經(jīng)切斷術(shù)治療極重度代償性多汗一例. 中國胸心血管外科臨床雜志, 2024, 31(7): 1071-1073. doi: 10.7507/1007-4848.202403035
TU Yuanrong, DU Quan, CHEN Jianfeng, LIN Min, FENG Zhi. Endoscopicexpanded sympathotomy for the treatment of extremely severe compensatory hyperhidrosis:A case report. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(7): 1071-1073. doi: 10.7507/1007-4848.202403035
王培宇, 黃祺, 王少東, 陳先凱, 張瑞祥, 趙佳, 邱滿堂, 李印, 李向楠. 《全球癌癥統(tǒng)計數(shù)據(jù)2022》要點解讀. 中國胸心血管外科臨床雜志, 2024, 31(7): 933-954. doi: 10.7507/1007-4848.202405013
WANG Peiyu, HUANG Qi, WANG Shaodong, CHEN Xiankai, ZHANG Ruixiang,ZHAO Jia, QIU Mantang, LI Yin, LI Xiangnan. Interpretation of the key points of"Global cancer statistics 2022: GLOBOCAN estimates of incidence andmortality worldwide for 36 cancers in 185 countries". Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(7): 933-954. doi:10.7507/1007-4848.202405013
羅國慶, 盧瀟, 李定慧, 彭敏, 李寧, 耿慶. 2024年第5版《NCCN腫瘤臨床實踐指南：非小細胞肺癌》更新解讀. 中國胸心血管外科臨床雜志, 2024, 31(7): 955-961. doi: 10.7507/1007-4848.202405046
LUO Guoqing, LU Xiao, LI Dinghui, PENG Min, LI Ning, GENG Qing.Interpretation of the updated NCCN clinical practice guidelines in oncology:Non-small cell lung cancer (version 5. 2024). Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(7): 955-961. doi:10.7507/1007-4848.202405046
徐奕, 陳東來, 徐學(xué)君, 張永勝, 段善州, 陳勇兵, 譚黎杰. 氣腔播散對手術(shù)決策的影響及冰凍切片識別氣腔播散準確性的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2024, 31(6): 900-909. doi: 10.7507/1007-4848.202211048
XU Yi, CHEN Donglai, XU Xuejun, ZHANG Yongsheng, DUAN Shanzhou, CHENYongbing, TAN Lijie. Impact of tumor spread through air spaces on surgicaldecision-making and accuracy of identifying spread through air spaces on frozensections: A systematic review and meta-analysis. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(6): 900-909. doi:10.7507/1007-4848.202211048
潘高澗, 葉冠志, 方韶韓, 朱曉雷, 劉鴻鳴, 李寧, 耿國軍, 姜杰. ChatGPT應(yīng)用于醫(yī)學(xué)臨床實踐及倫理探索. 中國胸心血管外科臨床雜志, 2024, 31(6): 910-914. doi: 10.7507/1007-4848.202402032
PAN Gaojian, YE Guanzhi, FANG Shaohan, ZHU Xiaolei, LIU Hongming, LINing, GENG Guojun, JIANG Jie. Application and ethical exploration of ChatGPT inmedical clinical practice. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(6): 910-914. doi: 10.7507/1007-4848.202402032
洪子強, 茍文曦, 盛燕楠, 白向豆, 崔百強, 金大成, 茍云久. 胸腔鏡下R4與R3+R4胸交感神經(jīng)切斷術(shù)治療手足多汗癥近遠期療效的單中心回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(5): 733-738. doi: 10.7507/1007-4848.202209061
HONG Ziqiang, GOU Wenxi, SHENG Yannan, BAI Xiangdou, CUI Baiqiang,JIN Dacheng, GOU Yunjiu. Short- and long-term effects of R4 versus R3+R4endoscopic thoracic sympathicotomy for acrohyperhidrosis: A retrospectivecohort study in a single center. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(5): 733-738. doi: 10.7507/1007-4848.202209061
尹媛媛, 鄭娥, 李歡歡, 楊梅, 姚麗, 趙春林. 胸腹腔鏡食管癌術(shù)后不留置胃管安全性和成本效益的前瞻性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(5): 728-732. doi: 10.7507/1007-4848.202209063
YIN Yuanyuan, ZHENG E, LI Huanhuan, YANG Mei, YAO Li, ZHAO Chunlin.Safety and cost-benefit analysis of patients without gastric tube afterthoracolaparoscopic esophagectomy: A prospective cohort study. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2024, 31(5): 728-732. doi:10.7507/1007-4848.202209063
王昱程, 卓澤國, 仲夏, 趙永生, 林一丹. 食管鱗癌近端食管發(fā)生擴張時不同胸內(nèi)吻合策略654例的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(5): 710-717. doi: 10.7507/1007-4848.202303035
WANG Yucheng, ZHUO Zeguo, ZHONG Xia, ZHAO Yongsheng, LIN Yidan.Different intrathoracic anastomotic strategies for proximal esophagealdilatation in 654 patients with esophageal: A retrospective cohort study.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(5):710-717. doi: 10.7507/1007-4848.202303035
王鋒, 袁宇航, 王晨晗, 胡文滕, 何立, 楊文文, 孫碩, 張敏, 韓彪. 達芬奇機器人與胸腔鏡外科治療后縱隔腫物臨床療效比較的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(5): 695-701. doi: 10.7507/1007-4848.202303038
WANG Feng, YUAN Yuhang, WANG Chenhan, HU Wenteng, HE Li, YANGWenwen, SUN Shuo, ZHANG Min, HAN Biao. The clinical efficacy of Da Vinci robotversus video-assisted thoracoscopic surgery in the treatment of posteriormediastinal tumors: A retrospective cohort study. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(5): 695-701. doi:10.7507/1007-4848.202303038
張功偉, 劉紅梅, 張宏偉, 余海. 術(shù)中呼氣末正壓對胸腔鏡肺部手術(shù)后肺部并發(fā)癥影響的傾向性評分匹配研究. 中國胸心血管外科臨床雜志, 2024, 31(5): 702-709. doi: 10.7507/1007-4848.202311050
ZHANG Gongwei, LIU Hongmei, ZHANG Hongwei, YU Hai. The associationof intraoperative positive end-expiratory pressure with pulmonary complicationsafter thoracoscopic lung surgery: A propensity score-matching study. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(5): 702-709.doi: 10.7507/1007-4848.202311050
支修益, 王潔, 劉倫旭, 趙軍, 中國醫(yī)藥教育協(xié)會肺癌醫(yī)學(xué)教育委員會，北京醫(yī)學(xué)獎勵基金會肺癌醫(yī)學(xué)青年專家委員會, 中國老年保健協(xié)會肺癌專業(yè)委員會. 中國肺癌骨轉(zhuǎn)移臨床診療指南（2024版）. 中國胸心血管外科臨床雜志, 2024, 31(5): 643-654. doi: 10.7507/1007-4848.202402042
ZHI Xiuyi, WANG Jie, LIU Lunxu, ZHAO Jun, Lung Cancer MedicalEducation Committee of Chinese Medicine Education Association, Youth ExpertCommittee on Lung Cancer of Beijing Medical Award Foundation, Lung CancerProfessional Committee of China Geriatric Health Association. Chinese clinicalguidelines on diagnosis and treatment of lung cancer bone metastasis (version2024). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(5): 643-654. doi: 10.7507/1007-4848.202402042
王會新, 李倩, 侯曉雯, 史新竹, 馮旭. 肺腺癌ceRNA調(diào)控網(wǎng)絡(luò)構(gòu)建及AFAP1-AS1功能驗證. 中國胸心血管外科臨床雜志, 2024, 31(4): 576-584. doi: 10.7507/1007-4848.202207067
WANG Huixin, LI Qian, HOU Xiaowen, SHI Xinzhu, FENG Xu. Foundationof ceRNA networks and functional validation of AFAP1-AS1 in lungadenocarcinoma. Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2024, 31(4): 576-584. doi: 10.7507/1007-4848.202207067
袁磊, 沈志明, 孫飛, 單一波, 盧毅, 朱劍煒, 史宏燦. 預(yù)測非小細胞肺癌免疫治療療效生物標志物的研究前沿與熱點分析. 中國胸心血管外科臨床雜志, 2024, 31(4): 562-569. doi: 10.7507/1007-4848.202208033
YUAN Lei, SHEN Zhiming, SUN Fei, SHAN Yibo, LU Yi, ZHU Jianwei, SHIHongcan. Frontier and hotspot of biomarkers for predicting the efficacy ofimmunotherapy in non-small cell lung cancer. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(4): 562-569. doi:10.7507/1007-4848.202208033
修語池, 劉博, 孟浩, 丁仁泉, 劉星池, 王仕祺, 胡博瀟, 吳瓊, 張國慶, 許世廣. 無管化三孔與傳統(tǒng)單操作孔胸腔鏡手術(shù)治療胸腺腫瘤的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(4): 546-550. doi: 10.7507/1007-4848.202208027
XIU Yuchi, LIU Bo, MENG Hao, DING Renquan, LIU Xingchi, WANG Shiqi,HU Boxiao, WU Qiong, ZHANG Guoqing, XU Shiguang. Tubeless three-port versusconventional single utility port thoracoscopic surgery in the treatment ofthymic tumors: A retrospective cohort study. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(4): 546-550. doi:10.7507/1007-4848.202208027
孫曾鋒, 劉軍強, 范博士, 宋偉安, 岳彩迎, 狄守迎, 趙嘉華, 周少華, 東海, 王居巳, 陳思禹, 龔太乾. 微創(chuàng)食管切除術(shù)聯(lián)合三野或二野淋巴結(jié)清掃術(shù)治療食管鱗狀細胞癌257例近期療效的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(4): 556-561. doi: 10.7507/1007-4848.202208021
SUN Zengfeng, LIU Junqiang, FAN Boshi, SONG Weian, YUE Caiying, DIShouying, ZHAO Jiahua, ZHOU Shaohua, DONG Hai, WANG Jusi, CHEN Siyu, GONGTaiqian. Short-term efficacy of minimally invasive esophagectomy combined withthree-field versus two-field lymphadenectomy for 257 patients with esophagealsquamous cell carcinoma: A retrospective cohort study. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(4): 556-561. doi:10.7507/1007-4848.202208021
徐璐, 路子蘊, 邱莉華, 許華曄, 王濤, 史敏科, 馬正良, 李冰冰. 日間胸腔鏡手術(shù)患者圍術(shù)期安全性及延遲出院危險因素分析. 中國胸心血管外科臨床雜志, 2024, 31(4): 551-555. doi: 10.7507/1007-4848.202208040
XU Lu, LU Ziyun, QIU Lihua, XU Huaye, WANG Tao, SHI Minke, MAZhengliang, LI Bingbing. Safety analysis of video-assisted thoracic surgery inDay Care Unit and the risk factors for delayed discharge. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(4): 551-555. doi:10.7507/1007-4848.202208040
冉興強, 施貴冬, 李洋云, 楊博, 付茂勇. 免疫檢查點抑制劑在食管癌新輔助治療中的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(4): 621-630. doi: 10.7507/1007-4848.202208068
RAN Xingqiang, SHI Guidong, LI Yangyun, YANG Bo, FU Maoyong.Progress of immune checkpoint inhibitors in neoadjuvant therapy for esophagealcancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(4): 621-630. doi: 10.7507/1007-4848.202208068
趙珂嘉, 劉成武, 劉倫旭. 《IASLC第九版肺癌TNM分期》解讀. 中國胸心血管外科臨床雜志, 2024, 31(4): 489-497. doi: 10.7507/1007-4848.202403015
ZHAO Kejia, LIU Chengwu, LIU Lunxu. Interpretation of the IASLCninth edition of the TNM classification for lung cancer. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(4): 489-497. doi:10.7507/1007-4848.202403015
羅瑞武, 黃桁, 程豪, 倪思語, 付思怡, 錢欽春, 楊俊杰, 陳鑫龍, 黃涵禹, 宗正東, 趙玉娟, 秦宇鶴, 何城誠, 吳野, 文紅英, 田東. 鹽亭縣食管癌高發(fā)區(qū)危險因素聚集性的相關(guān)分析. 中國胸心血管外科臨床雜志, 2024, 31(3): 385-391. doi: 10.7507/1007-4848.202206023
LUO Ruiwu, HUANG Heng, CHENG Hao, NI Siyu, FU Siyi, QIAN Qinchun,YANG Junjie, CHEN Xinlong, HUANG Hanyu, ZONG Zhengdong, ZHAO Yujuan, QIN Yuhe,HE Chengcheng, WU Ye, WEN Hongying, TIAN Dong. Clustering analysis of riskfactors in high-incidence areas of esophageal cancer in Yanting county. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(3): 385-391.doi: 10.7507/1007-4848.202206023
王琪, 孫飛, 單一波, 史宏燦. 抗生素及質(zhì)子泵抑制劑經(jīng)腸道菌群影響肺癌免疫治療的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(3): 462-466. doi: 10.7507/1007-4848.202206024
WANG Qi, SUN Fei, SHAN Yibo, SHI Hongcan. Research progress on theeffect of antibiotics and proton pump inhibitors on immunotherapy of lungcancer through intestinal flora. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(3): 462-466. doi: 10.7507/1007-4848.202206024
敬濤, 宋鐵牛, 魏小平, 馮海明, 張少博, 王成, 蔣鵬, 李斌. 單發(fā)純磨玻璃結(jié)節(jié)為表現(xiàn)的肺轉(zhuǎn)移癌一例. 中國胸心血管外科臨床雜志, 2024, 31(3): 485-488. doi: 10.7507/1007-4848.202207003
JING Tao, SONG Tieniu, WEI Xiaoping, FENG Haiming, ZHANG Shaobo,WANG Cheng, JIANG Peng, LI Bin. Lung metastasis manifested by solitary pureground-glass opacity: A case report. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(3): 485-488. doi: 10.7507/1007-4848.202207003
費翔, 楊立信, 李鑫, 朱吉, 金海, 陳和忠, 陸超敬. 反穿刺法微創(chuàng)Ivor-Lewis食管癌根治術(shù)在食管下段癌中應(yīng)用的單中心回顧性分析. 中國胸心血管外科臨床雜志, 2024, 31(3): 364-370. doi: 10.7507/1007-4848.202207004
FEI Xiang, YANG Lixin, LI Xin, ZHU Ji, JIN Hai, CHEN Hezhong, LUChaojing. Reverse-puncture anastomosis in minimally invasive Ivor-Lewisesophagectomy for lower esophageal carcinoma: A single-center retrospectivestudy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(3): 364-370. doi: 10.7507/1007-4848.202207004
楊文文, 何立, 張敏, 孫碩, 王峰, 馬敏杰, 韓彪. 單細胞轉(zhuǎn)錄組測序技術(shù)在非小細胞肺癌免疫微環(huán)境分析中應(yīng)用的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(3): 467-472. doi: 10.7507/1007-4848.202206064
YANG Wenwen, HE Li, ZHANG Min, SUN Shuo, WANG Feng, MA Minjie, HANBiao. Research progress of single-cell RNA sequencing in the immunemicroenvironment analysis of non-small cell lung cancer. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(3): 467-472. doi:10.7507/1007-4848.202206064
成名, 丁仁泉, 徐惟, 王希龍, 王述民. 數(shù)字化引流系統(tǒng)在達芬奇機器人肺葉切除術(shù)后應(yīng)用的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(3): 403-407. doi: 10.7507/1007-4848.202207010
CHENG Ming, DING Renquan, XU Wei, WANG Xilong, WANG Shumin.Application of digital drainage system after da Vinci robot-assisted lobectomy:A retrospective cohort study. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(3): 403-407. doi: 10.7507/1007-4848.202207010
洪子強, 金大成, 白向豆, 成濤, 吳旭升, 崔百強, 茍云久. 機器人輔助胸腔鏡手術(shù)治療后縱隔神經(jīng)源性腫瘤的臨床療效分析. 中國胸心血管外科臨床雜志, 2024, 31(3): 408-412. doi: 10.7507/1007-4848.202207068
HONG Ziqiang, JIN Dacheng, BAI Xiangdou, CHENG Tao, WU Xusheng, CUIBaiqiang, GOU Yunjiu. Clinical efficacy of robot-assisted thoracoscopic surgeryfor posterior mediastinal neurogenic tumour. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(3): 408-412. doi:10.7507/1007-4848.202207068
白向豆, 茍文曦, 洪子強, 崔百強, 金大成, 茍云久. 不同手術(shù)入路治療Siewert Ⅱ型食管胃結(jié)合部腺癌臨床療效的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(3): 371-375. doi: 10.7507/1007-4848.202207079
BAI Xiangdou, GOU Wenxi, HONG Ziqiang, CUI Baiqiang, JIN Dacheng,GOU Yunjiu. Clinical efficacy of different surgical approaches in the treatmentof Siewert type Ⅱ adenocarcinoma of esophagogastric junction: A retrospective cohortstudy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024,31(3): 371-375. doi: 10.7507/1007-4848.202207079
中國醫(yī)療保健國際交流促進會胸外科分會, 中國抗癌協(xié)會肺部腫瘤整合康復(fù)專業(yè)委員會, 浙江省醫(yī)師協(xié)會胸外科醫(yī)師分會. 4K熒光高端國產(chǎn)醫(yī)用內(nèi)窺鏡全國胸外科臨床應(yīng)用評價專家共識（2023）. 中國胸心血管外科臨床雜志, 2024, 31(3): 337-342. doi: 10.7507/1007-4848.202311071
Thoracic Surgery Branch of China International Exchange andPromotive Association for Medical and Health Care, The Pulmonary TumorIntegration and Rehabilitation Professional Committee of the China Anti-CancerAssociation, Thoracic Surgeon Branch of Zhejiang Medical Doctors Association.Nationwide expert consensus on the clinical application and evaluation of 4Kfluorescence high-end medical endoscopes in thoracic surgery (2023). ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(3): 337-342.doi: 10.7507/1007-4848.202311071
楊博, 李斌, 蔣鵬, 張少博, 任美玉, 蘇志鵬. 自體髂骨移植聯(lián)合鈦板胸骨重建一例. 中國胸心血管外科臨床雜志, 2024, 31(2): 329-332. doi: 10.7507/1007-4848.202203063
YANG Bo, LI Bin, JIANG Peng, ZHANG Shaobo, REN Meiyu, SU Zhipeng.Autologous ilium graft combination with titanium plate for sternalreconstruction: A case report. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(2): 329-332. doi: 10.7507/1007-4848.202203063
姚益, 胡秋霞, 楊彥輝, 謝曉陽, 王毅, 李曉亮, 羅雷, 李季. 囊腔型肺結(jié)節(jié)CT影像學(xué)特征探究及良惡性預(yù)測模型的建立. 中國胸心血管外科臨床雜志, 2024, 31(2): 249-254. doi: 10.7507/1007-4848.202203071
YAO Yi, HU Qiuxia, YANG Yanhui, XIE Xiaoyang, WANG Yi, LI Xiaoliang,LUO Lei, LI Ji. Exploration of CT imaging features of cystic pulmonary nodulesand establishment of a prediction modelfor benign and malignant pulmonary nodules. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(2): 249-254. doi:10.7507/1007-4848.202203071
洪子強, 金大成, 白向豆, 崔百強, 茍云久. 非小細胞肺癌生物標志物的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(2): 311-318. doi: 10.7507/1007-4848.202204084
HONG Ziqiang, JIN Dacheng, BAI Xiangdou, CUI Baiqiang, GOU Yunjiu.Research progress of biomarkers for non-small cell lung cancer. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2024, 31(2): 311-318. doi:10.7507/1007-4848.202204084
譚子輝, 楊小芳, 楊浩賢, 林鵬, 傅劍華. 單孔胸腔鏡縱形切口新輔助免疫聯(lián)合化療后左上肺癌根治術(shù)出血處理手術(shù)視頻要點. 中國胸心血管外科臨床雜志, 2024, 31(2): 4-5. doi: 10.7507/1007-4848.202307074
向潤, 謝少華, 廖瓊, 李強, 邵偉康, 李娟. 基于全外顯子組測序的胸腺癌基因組分析和生物標志物探索的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(2): 288-303. doi: 10.7507/1007-4848.202310011
XIANG Run, XIE Shaohua, LIAO Qiong, LI Qiang, SHAO Weikang, LI Juan.Genomic analysis and biomarker discovery of thymic cancer based on whole exomesequencing: A retrospective cohort study. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2024, 31(2): 288-303. doi:10.7507/1007-4848.202310011
魏立, 邢文群, 楊洋, 代表《河南省食管癌新輔助免疫治療診療路徑》編寫組. 河南省食管癌新輔助免疫治療診療路徑. 中國胸心血管外科臨床雜志, 2024, 31(2): 186-195. doi: 10.7507/1007-4848.202308005
WEI Li, XING Wenqun, YANG Yang, representatives of the Writing Groupof Diagnosis and Treatment Pathway of Neoadjuvant Immunotherapy for EsophagealCancer in Henan province. Diagnosis and treatment pathway of neoadjuvantimmunotherapy for esophageal cancer in Henan province. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(2): 186-195. doi:10.7507/1007-4848.202308005
周凱, 鄧朝強, 張揚. 經(jīng)手術(shù)切除肺癌腫瘤大小測量和臨床T分期準確性：1 880例患者的回顧性分析. 中國胸心血管外科臨床雜志, 2024, 31(2): 223-228. doi: 10.7507/1007-4848.202310061
ZHOU Kai, DENG Chaoqiang, ZHANG Yang. The accuracy of tumor sizemeasurement and clinical T staging for resected lung cancer: Retrospectiveanalysis of 1 880 patients. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2024, 31(2): 223-228. doi: 10.7507/1007-4848.202310061
梁林川, 彭智愚, 林華杭, 周柯, 梅建東. 急性壞死性縱隔炎176例臨床特征及轉(zhuǎn)歸的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2024, 31(2): 243-248. doi: 10.7507/1007-4848.202309011
LIANG Linchuan, PENG Zhiyu, LIN Huahang, ZHOU Ke, MEI Jiandong.Clinical characteristics and outcomes of 176 patients with acute necrotizingmediastinitis: A retrospective cohort study. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(2): 243-248. doi:10.7507/1007-4848.202309011
劉堅, 魏立, 祝李, 胡帥, 夏天, 魏文學(xué). 左肺上葉尖后段支氣管新分型及其臨床意義. 中國胸心血管外科臨床雜志, 2024, 31(1): 92-98. doi: 10.7507/1007-4848.202203017
LIU Jian, WEI Li, ZHU Li, HU Shuai, XIA Tian, WEI Wenxue. A newclassification of left apicoposterior segmental bronchus and its clinicalsignificance. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2024, 31(1): 92-98. doi: 10.7507/1007-4848.202203017
韓丁培, 楊溯, 陳香, 郭威, 項捷, 朱良綱, 車嘉銘, 杭鈞彪, 李鶴成. 多種定位方法在亞肺葉切除治療肺小結(jié)節(jié)中的臨床應(yīng)用現(xiàn)狀. 中國胸心血管外科臨床雜志, 2024, 31(1): 160-165. doi: 10.7507/1007-4848.202203048
HAN Dingpei, YANG Su, CHEN Xiang, GUO Wei, XIANG Jie, ZHU Lianggang,CHE Jiaming, HANG Junbiao, LI Hecheng. Clinical application status of multiplelocalization methods in the treatment of pulmonary nodules by sub-lobectomy.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(1):160-165. doi: 10.7507/1007-4848.202203048
李欣, 王哲, 袁慧, 官彬, 關(guān)正. 日均運動步數(shù)與老年患者胸腔鏡肺葉切除術(shù)后肺部并發(fā)癥關(guān)系的傾向性評分匹配研究. 中國胸心血管外科臨床雜志, 2024, 31(1): 99-104. doi: 10.7507/1007-4848.202203067
LI Xin, WANG Zhe, YUAN Hui, GUAN Bin, GUAN Zheng. The relationshipbetween mean daily step counts and pulmonary complications after thoracoscopiclobectomy in elderly patients: A propensity score matching study. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(1): 99-104.doi: 10.7507/1007-4848.202203067
洪子強, 金大成, 白向豆, 崔百強, 茍云久. 熱消融治療肺癌的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(1): 166-172. doi: 10.7507/1007-4848.202203061
HONG Ziqiang, JIN Dacheng, BAI Xiangdou, CUI Baiqiang, GOU Yunjiu.Research advances in thermal ablation for lung cancer. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2024, 31(1): 166-172. doi:10.7507/1007-4848.202203061
周連田, 趙可輝, 張志強. 人工智能在肺腺癌病理學(xué)亞型分型及基因表達分析中應(yīng)用的研究進展. 中國胸心血管外科臨床雜志, 2024, 31(1): 145-152. doi: 10.7507/1007-4848.202304001
ZHOU Liantian, ZHAO Kehui, ZHANG Zhiqiang. Research progress ofartificial intelligence in pathological subtypes classification and geneexpression analysis of lung adenocarcinoma. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2024, 31(1): 145-152. doi:10.7507/1007-4848.202304001
唐川君, 袁湘蕾, 張瓊英, 胡兵. 人工智能在食管癌診斷中的應(yīng)用進展. 中國胸心血管外科臨床雜志, 2024, 31(1): 153-159. doi: 10.7507/1007-4848.202306032
TANG Chuanjun, YUAN Xianglei, ZHANG Qiongying, HU Bing. Applicationprogress of artificial intelligence in the diagnosis of esophageal cancer.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(1):153-159. doi: 10.7507/1007-4848.202306032
宋毅杰, 徐修遠, 王寧, 賈霜, 袁曄, 蔣良雙, 姚曉軍. 肺結(jié)核外科數(shù)據(jù)庫系統(tǒng)與區(qū)域信息共享平臺構(gòu)建. 中國胸心血管外科臨床雜志, 2023, 30(12): 1749-1756. doi: 10.7507/1007-4848.202307005
SONG Yijie, XU Xiuyuan, WANG Ning, JIA Shuang, YUAN Ye, JIANGLiangshuang, YAO Xiaojun. Construction of a thoracic surgery database systemand platform for regional information interactions on pulmonary tuberculosis.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(12):1749-1756. doi: 10.7507/1007-4848.202307005
徐心峰, 聞偉, 朱全, 陳亮. 右上肺跨亞段動脈分型的單中心回顧性研究. 中國胸心血管外科臨床雜志, 2023, 30(12): 1737-1742. doi: 10.7507/1007-4848.202306030
XU Xinfeng, WEN Wei, ZHU Quan, CHEN Liang. Classification oftrans-subsegmental artery in the right upper lobe: A retrospective study in asingle center. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(12): 1737-1742. doi: 10.7507/1007-4848.202306030
傅方求, 張揚, 陳海泉. 如何認識和理解肺腺癌外科治愈窗口期. 中國胸心血管外科臨床雜志, 2023, 30(12): 1674-1677. doi: 10.7507/1007-4848.202310004
FU Fangqiu, ZHANG Yang, CHEN Haiquan. The surgical curative timewindow for lung adenocarcinoma: A comprehensive understanding. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2023, 30(12): 1674-1677. doi:10.7507/1007-4848.202310004
劉星池, 許世廣, 劉博, 劉大治, 徐惟, 丁仁泉, 李博, 李思桐, 王述民. 達芬奇機器人與劍突下胸腔鏡前縱隔腫瘤切除術(shù)療效比較的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2023, 30(11): 1551-1555. doi: 10.7507/1007-4848.202112015
LIU Xingchi, XU Shiguang, LIU Bo, LIU Dazhi, XU Wei, DING Renquan,LI Bo, LI Sitong, WANG Shumin. Da Vinci robotic versus thoracoscopic surgeryvia subxiphoid approach for treatment of anterior mediastinal tumor: Aretrospective cohort study. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(11): 1551-1555. doi:10.7507/1007-4848.202112015
蔡永圣, 陳青山, 董紅紅, 陳碩, 李欣, 葉鑫, 傅毅立, 陳其瑞, 游賓, 苗勁柏, 李輝, 胡濱. 支氣管擴張癥術(shù)后靜脈血栓栓塞癥與術(shù)前血紅蛋白含量的關(guān)系分析. 中國胸心血管外科臨床雜志, 2023, 30(11): 1561-1566. doi: 10.7507/1007-4848.202201073
CAI Yongsheng, CHEN Qingshan, DONG Honghong, CHEN Shuo, LI Xin, YEXin, FU Yili, CHEN Qirui, YOU Bin, MIAO Jinbai, LI Hui, HU Bin. Analysis of therelationship between venous thromboembolism after surgical treatment forbronchiectasis and preoperative hemoglobin amount. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2023, 30(11): 1561-1566. doi:10.7507/1007-4848.202201073
賀海奇, 趙恒, 馬磊, 王哲, 溫小鵬, 張佳, 賈卓奇, 吳齊飛, 張勇, 張廣健, 付軍科. 基于加速康復(fù)外科理念手汗癥日間手術(shù)安全性與可行性的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2023, 30(11): 1556-1560. doi: 10.7507/1007-4848.202202028
HE Haiqi, ZHAO Heng, MA Lei, WANG Zhe, WEN Xiaopeng, ZHANG Jia, JIAZhuoqi, WU Qifei, ZHANG Yong, ZHANG Guangjian, FU Junke. The feasibility andsafety of day surgery for palmar hyperhidrosis based on the principles ofenhanced recovery after surgery: A retrospective cohort study. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2023, 30(11): 1556-1560. doi:10.7507/1007-4848.202202028
成濤, 金大成, 崔百強, 黃大新, 茍云久. 奈達鉑與順鉑聯(lián)合吉西他濱治療晚期肺鱗狀細胞癌近期療效和安全性的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2023, 30(11): 1638-1644. doi: 10.7507/1007-4848.202202023
CHENG Tao, JIN Dacheng, CUI Baiqiang, HUANG Daxin, GOU Yunjiu.Short-term efficacy and safety of nedaplatin versus cisplatin combined withgemcitabine for treatment of advanced lung squamous cell carcinoma: Asystematic review and meta-analysis. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(11): 1638-1644. doi:10.7507/1007-4848.202202023
毛銘懿, 劉磊, 李單青, 陳野野. 縱隔原發(fā)異位甲狀腺乳頭狀癌一例. 中國胸心血管外科臨床雜志, 2023, 30(11): 1666-1668. doi: 10.7507/1007-4848.202208026
MAO Mingyi, LIU Lei, LI Shanqing, CHEN Yeye. Mediastinal ectopicpapillary thyroid carcinoma: A case report. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2023, 30(11): 1666-1668. doi:10.7507/1007-4848.202208026
劉誠信, 吳東聲, 周健, 寇瑛琍, 陳龍奇, 林鋒. 四川省胸壁外科發(fā)展現(xiàn)狀調(diào)查. 中國胸心血管外科臨床雜志, 2023, 30(11): 1567-1570. doi: 10.7507/1007-4848.202211100
LIU Chengxin, WU Dongsheng, ZHOU Jian, KOU Yingli, CHEN Longqi, LINFeng. A questionnaire study investigating the current development status ofchest wall surgery in Sichuan Province. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2023, 30(11): 1567-1570. doi:10.7507/1007-4848.202211100
周和玲, 蔣艷華, 吳傳美, 陳艷麗, 唐秋月, 羅珊, 王雅琴, 廖佳, 魏星, 代珍, 戴維, 石丘玲. 肺癌患者術(shù)后住院期間便秘現(xiàn)狀及其影響因素分析. 中國胸心血管外科臨床雜志, 2023, 30(10): 1402-1406. doi: 10.7507/1007-4848.202109021
ZHOU Heling, JIANG Yanhua, WU Chuanmei, CHEN Yanli, TANG Qiuyue, LUOShan, WANG Yaqin, LIAO Jia, WEI Xing, DAI Zhen, DAI Wei, SHI Qiuling. Analysisof constipation status and influencing factors in patients with lung cancerduring postoperative hospitalization. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(10): 1402-1406. doi:10.7507/1007-4848.202109021
洪子強, 金大成, 白向豆, 成濤, 吳旭升, 崔百強, 茍云久. 機器人與胸腔鏡輔助胸腺切除術(shù)療效及安全性比較的更新系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2023, 30(10): 1458-1466. doi: 10.7507/1007-4848.202203037
HONG Ziqiang, JIN Dacheng, BAI Xiangdou, CHENG Tao, WU Xusheng, CUIBaiqiang, GOU Yunjiu. Efficacy and safety of robot-assisted thymectomy versusvideo-assisted thoracoscopic thymectomy: An updated systematic review andmeta-analysis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(10): 1458-1466. doi: 10.7507/1007-4848.202203037
謝太吉, 郭玲, 龔若?, 唐前龍, 向潤, 戴維, 謝少華, 周可, 謝天鵬, 李強. 胸腺瘤患者的臨床病理特征及預(yù)后影響因素分析. 中國胸心血管外科臨床雜志, 2023, 30(10): 1407-1414. doi: 10.7507/1007-4848.202210098
XIE Taiji, GUO Ling, GONG Ruoyan, TANG Qianlong, XIANG Run, DAI Wei,XIE Shaohua, ZHOU Ke, XIE Tianpeng, LI Qiang. Analysis of theclinicopathological characteristics of thymoma patients and the influencingfactors for prognosis. Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2023, 30(10): 1407-1414. doi: 10.7507/1007-4848.202210098
姚靈琦, 常嘯巖, 沈志平, 王開宇, 李毅, 徐昊, 張臨友. 全孔機器人與胸腔鏡在ⅠA期非小細胞肺癌肺葉切除術(shù)中療效比較的回顧性隊列研究. 中國胸心血管外科臨床雜志, 2023, 30(10): 1390-1395. doi: 10.7507/1007-4848.202303029
YAO Lingqi, CHANG Xiaoyan, SHEN Zhiping, WANG Kaiyu, LI Yi, XU Hao,ZHANG Linyou. The clinical efficacy of all-port robotic versus thoracoscopiclobectomy in stageⅠA non-small cell lung cancer: A retrospective cohort study. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(10):1390-1395. doi: 10.7507/1007-4848.202303029
齊康, 林鋼, 張西寧, 劉海波, 黃偉明, 劉敬偉, 李簡. 優(yōu)先支氣管成形在單孔胸腔鏡肺上葉切除術(shù)中應(yīng)用的單中心回顧性分析. 中國胸心血管外科臨床雜志, 2023, 30(10): 1422-1428. doi: 10.7507/1007-4848.202307011
QI Kang, LIN Gang, ZHANG Xining, LIU Haibo, HUANG Weiming, LIUJingwei, LI Jian. Clinical application of preferential manual bronchoplasty insingle-port video-assisted thoracoscopic upper lobectomy: A retrospectiveanalysis in a single center. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(10): 1422-1428. doi:10.7507/1007-4848.202307011
吳漢然, 柳常青, 解明然, 代表安徽省醫(yī)學(xué)會胸外科專業(yè)委員會, 安徽省臨床腫瘤學(xué)會胸部腫瘤外科專業(yè)委員會. 充氣式縱隔鏡食管癌切除術(shù)中國專家共識. 中國胸心血管外科臨床雜志, 2023, 30(10): 1367-1376. doi: 10.7507/1007-4848.202308007
WU Hanran, LIU Changqing, XIE Mingran, Representatives of ThoracicSurgery Committee of Anhui Medical Association, Thoracic Oncology SurgeryProfessional Committee of Anhui Clinical Oncology Society. Chinese expertconsensus on the inflatable video-assisted mediastinoscopic transhiatalesophagectomy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(10): 1367-1376. doi: 10.7507/1007-4848.202308007
高雪涵, 陳野野, 張家齊, 李單青. 18例原發(fā)性縱隔卵黃囊瘤的臨床診治及預(yù)后特點. 中國胸心血管外科臨床雜志, 2023, 30(9): 1280-1289. doi: 10.7507/1007-4848.202107089
GAO Xuehan, CHEN Yeye, ZHANG Jiaqi, LI Shanqing. Diagnosis,treatment and prognosis of primary mediastinal yolk sac tumor in 18 patients.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(9):1280-1289. doi: 10.7507/1007-4848.202107089
周小芹, 劉慧珍, 王婷, 李旭, 施帆帆, 康德英. 腫瘤藥物臨床試驗設(shè)計之傘式試驗. 中國胸心血管外科臨床雜志, 2023, 30(9): 1228-1234. doi: 10.7507/1007-4848.202303024
ZHOU Xiaoqin, LIU Huizhen, WANG Ting, LI Xu, SHI Fanfan, KANGDeying. Umbrella trial for clinical trial design of oncology drugs. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(9):1228-1234. doi: 10.7507/1007-4848.202303024
鄧朝強, 江晨宇, 張揚, 陳海泉. 選擇性縱隔淋巴結(jié)清掃：精準醫(yī)學(xué)時代的精準手術(shù). 中國胸心血管外科臨床雜志, 2023, 30(9): 1224-1227. doi: 10.7507/1007-4848.202307027
DENG Chaoqiang, JIANG Chenyu, ZHANG Yang, CHEN Haiquan. Selectivemediastinal lymph node dissection: Precision surgery in the era of precisionmedicine. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(9): 1224-1227. doi: 10.7507/1007-4848.202307027
劉云飛, 王小文, 李林峻, 張誠, 蔣迎九, 吳慶琛. 術(shù)前合并心律失常的非小細胞肺癌患者圍術(shù)期安全性及近期預(yù)后的臨床分析. 中國胸心血管外科臨床雜志, 2023, 30(8): 1158-1163. doi: 10.7507/1007-4848.202109075
LIU Yunfei, WANG Xiaowen, LI Linjun, ZHANG Cheng, JIANG Yingjiu, WUQingchen. Clinical analysis of perioperative safety and short-term prognosis ofnon-small cell lung cancer patients with preoperative arrhythmia. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(8):1158-1163. doi: 10.7507/1007-4848.202109075
衣騰飛, 秦坤, 邵盛騰, 李爍, 劉玉洪. 系統(tǒng)性與葉特異性淋巴結(jié)清掃治療cⅠA期肺腺癌療效比較的單中心傾向性評分匹配分析. 中國胸心血管外科臨床雜志, 2023, 30(8): 1143-1150. doi: 10.7507/1007-4848.202111046
YI Tengfei, QIN Kun, SHAO Shengteng, LI Shuo, LIU Yuhong. Efficacyof systematic versus lobe-specific lymph node dissection in the treatment ofclinicalⅠA stage lung adenocarcinoma: A propensity score matching study in asingle center. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(8): 1143-1150. doi: 10.7507/1007-4848.202111046
劉磊, 張毅, 支修益, 劉寶東. 經(jīng)皮肺部腫瘤射頻消融術(shù)中并發(fā)癥的影響因素分析. 中國胸心血管外科臨床雜志, 2023, 30(8): 1164-1168. doi: 10.7507/1007-4848.202111047
LIU Lei, ZHANG Yi, ZHI Xiuyi, LIU Baodong. Analysis of influencingfactors for complications during percutaneous radiofrequency ablation ofpulmonary tumor. Chinese Journal of Clinical Thoracic and CardiovascularSurgery, 2023, 30(8): 1164-1168. doi: 10.7507/1007-4848.202111047
王振, 顧浩宇, 羅靜, 朱熙煦, 宋勇, 申翼, 強勇. 新輔助免疫治療聯(lián)合體部立體定向放療Ⅲ/N2期非小細胞肺癌三例. 中國胸心血管外科臨床雜志, 2023, 30(8): 1210-1216. doi: 10.7507/1007-4848.202210022
WANG Zhen, GU Haoyu, LUO Jing, ZHU Xixu, SONG Yong, SHEN Yi, QIANGYong. Neoadjuvant immunotherapy combined with stereotactic body radiationtherapy for stage Ⅲ/N2 non-small cell lung cancer: Three cases reports. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2023, 30(8): 1210-1216. doi:10.7507/1007-4848.202210022
吳思凱, 王子民, 孫鏵, 朱成楚, 沈建飛. CALGB140503研究：亞肺葉切除是早期周圍型肺癌的標準術(shù)式？. 中國胸心血管外科臨床雜志, 2023, 30(8): 1097-1101. doi: 10.7507/1007-4848.202303086
WU Sikai, WANG Zimin, SUN Hua, ZHU Chengchu, SHEN Jianfei.CALGB140503 study: Is sublobectomy the standard procedure for early peripherallung cancer?. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(8): 1097-1101. doi: 10.7507/1007-4848.202303086
藺軍平, 孟于琪, 李斌, 馮海明, 李政. DDX46基因調(diào)控TE-1食管鱗狀細胞癌細胞侵襲轉(zhuǎn)移行為的相關(guān)性研究. 中國胸心血管外科臨床雜志, 2023, 30(7): 1030-1037. doi: 10.7507/1007-4848.202204019
LIN Junping, MENG Yuqi, LI Bin, FENG Haiming, LI Zheng. Relationshipbetween DDX46 gene and invasion and metastasis behaviors of TE-1 esophagealsquamous cell carcinoma cells. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(7): 1030-1037. doi:10.7507/1007-4848.202204019
李昌頂, 李佳龍, 肖文光, 徐珊玲, 韓泳濤, 冷雪峰. 微創(chuàng)食管癌切除術(shù)后感染新型冠狀病毒兩例. 中國胸心血管外科臨床雜志, 2023, 30(7): 962-966. doi: 10.7507/1007-4848.202301038
LI Changding, LI Jialong, XIAO Wenguang, XU Shanling, HAN Yongtao,LENG Xuefeng. COVID-19 infection after minimally invasive esophagectomy: Twocases report. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(7): 962-966. doi: 10.7507/1007-4848.202301038
何哲, 朱啟航, 李祥麟, 湯德釗, 吳俊翰, 陳奕璋, 陳啟彬, 張其鵬, 徐恩五, 肖海平, 唐勇, 喬貴賓. 新型冠狀病毒感染后肺癌手術(shù)時機及安全性的多中心回顧性研究. 中國胸心血管外科臨床雜志, 2023, 30(7): 945-949. doi: 10.7507/1007-4848.202303012
HE Zhe, ZHU Qihang, LI Xianglin, TANG Dezhao, WU Junhan, CHENYizhang, CHEN Qibin, ZHANG Qipeng, XU Enwu, XIAO Haiping, TANG Yong, QIAOGuibin. Timing and safety of lung cancer surgery after SARS-CoV-2 infection: Amulticenter retrospective study. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(7): 945-949. doi: 10.7507/1007-4848.202303012
袁立功, 梅新宇. 2023年第一版《食管胃癌寡轉(zhuǎn)移的定義、診斷和治療：歐洲Delphi共識研究》解讀. 中國胸心血管外科臨床雜志, 2023, 30(7): 936-938. doi: 10.7507/1007-4848.202304080
YUAN Ligong, MEI Xinyu. Interpretation of the first edition ofdefinition, diagnosis and treatment of oligometastatic oesophagogastric cancer:A Delphi consensus study in Europe. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(7): 936-938. doi: 10.7507/1007-4848.202304080
嚴冬青, 殷茵, 王沛杰, 李昀. 胸腺瘤合并多發(fā)性肌炎及重癥肌無力一例. 中國胸心血管外科臨床雜志, 2023, 30(6): 924-926. doi: 10.7507/1007-4848.202210026
YAN Dongqing, YIN Yin, WANG Peijie, LI Yun. Thymoma complicated withpolymyositis and myasthenia gravis: A case report. Chinese Journal of ClinicalThoracic and Cardiovascular Surgery, 2023, 30(6): 924-926. doi:10.7507/1007-4848.202210026
黃玉煒, 王猛, 張永輝, 崔新征, 孫子瑞, 張志文, 史宸碩, 張清勇. α7煙堿型乙酰膽堿受體在重癥肌無力胸腺細胞中的表達及其功能. 中國胸心血管外科臨床雜志, 2023, 30(6): 897-902. doi: 10.7507/1007-4848.202212070
HUANG Yuwei, WANG Meng, ZHANG Yonghui, CUI Xinzheng, SUN Zirui,ZHANG Zhiwen, SHI Chenshuo, ZHANG Qingyong. Expression and function of α7 nicotinic acetylcholine receptor inthymocytes of myasthenia gravis patients. Chinese Journal of Clinical Thoracicand Cardiovascular Surgery, 2023, 30(6): 897-902. doi:10.7507/1007-4848.202212070
白向豆, 曾偉強, 崔百強, 王兵, 楊寧, 賀曉陽, 張斯淵, 金大成, 茍云久. 血管緊張素轉(zhuǎn)換酶2在非小細胞肺癌與SARS-CoV-2中共表達的研究進展. 中國胸心血管外科臨床雜志, 2023, 30(5): 773-778. doi: 10.7507/1007-4848.202105077
BAI Xiangdou, ZENG Weiqiang, CUI Baiqiang, WANG Bing, YANG Ning, HEXiaoyang, ZHANG Siyuan, JIN Dacheng, GOU Yunjiu. Research progress ofangiotensin converting enzyme 2 co-expression in non-small cell lung cancer andSARS-CoV-2. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2023, 30(5): 773-778. doi: 10.7507/1007-4848.202105077
戴越, 周帆, 鄭建偉, 穆軍升, 伯平, 尤斌. CDM3對人誘導(dǎo)多能干細胞與覆有基質(zhì)膠的聚己內(nèi)酯共培養(yǎng)制作心肌補片的影響. 中國胸心血管外科臨床雜志, 2023, 30(5): 738-745. doi: 10.7507/1007-4848.202206078
DAI Yue, ZHOU Fan, ZHENG Jianwei, MU Junsheng, BO Ping, YOU Bin.Effect of CDM3 on the co-culture of human induced pluripotent stem cells withmatrigel-coated polycaprolactone to make cardiac patch. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2023, 30(5): 738-745. doi:10.7507/1007-4848.202206078
郭嘉儀, 阿力木江·木明, 伊地力斯·阿吾提, 張海平, 張力為. 淋巴管與淋巴管內(nèi)皮細胞在食管癌淋巴轉(zhuǎn)移過程中的作用及變化. 中國胸心血管外科臨床雜志, 2023, 30(5): 766-772. doi: 10.7507/1007-4848.202207054
GUO Jiayi, ALIMUJIANG·Muming, EDRIS·Awut, ZHANG Haiping, ZHAGN Liwei. Changes and effects of lymphaticvessels and lymphatic endothelial cells in lymph node metastasis of esophagealcancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023,30(5): 766-772. doi: 10.7507/1007-4848.202207054
孟于琪, 李斌. 新型冠狀病毒感染對肺癌患者診療的影響. 中國胸心血管外科臨床雜志, 2023, 30(4): 635-640. doi: 10.7507/1007-4848.202301006
MENG Yuqi, LI Bin. The impact of COVID-19 on the diagnosis andtreatment of lung cancer. Chinese Journal of Clinical Thoracic andCardiovascular Surgery, 2023, 30(4): 635-640. doi: 10.7507/1007-4848.202301006
余海, 鄭宏, 莊蕙嘉, 韓楊, 黃治宇, 成都醫(yī)學(xué)會麻醉專業(yè)委員會. 新型冠狀病毒感染患者的圍手術(shù)期機械通氣策略推薦. 中國胸心血管外科臨床雜志, 2023, 30(4): 501-505. doi: 10.7507/1007-4848.202302022
YU Hai, ZHENG Hong, ZHUANG Huijia, HAN Yang, HUANG Zhiyu, TheSociety of Anesthesiology, Chengdu Medical Association. Perioperativemechanical ventilation strategy for COVID-19 patients: Recommendation. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(4): 501-505.doi: 10.7507/1007-4848.202302022
王曉瑋, 常帥, 宋文鵬, 車國衛(wèi). 低鈉血癥與非小細胞肺癌患者臨床病理及預(yù)后特征相關(guān)性的系統(tǒng)評價與Meta分析. 中國胸心血管外科臨床雜志, 2023, 30(3): 428-433. doi: 10.7507/1007-4848.202109016
WANG Xiaowei, CHANG Shuai, SONG Wenpeng, CHE Guowei. The associationof hyponatremia with clinicopathological and prognostic characteristics ofnon-small cell lung cancer patients: A systematic review and meta-analysis.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(3):428-433. doi: 10.7507/1007-4848.202109016
寧英澤, 倪乙洪, 陳芳軍, 強光亮. 新型冠狀病毒感染后胸外科手術(shù)時機選擇的研究進展. 中國胸心血管外科臨床雜志, 2023, 30(3): 344-349. doi: 10.7507/1007-4848.202301030
NING Yingze, NI Yihong, CHEN Fangjun, QIANG Guangliang. Researchprogress in the timing of thoracic surgery after SARS-CoV-2 infection. ChineseJournal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(3): 344-349.doi: 10.7507/1007-4848.202301030
范晨, 唐浩桓, 周奇, 孫飛虎, 丁偉, 孫磊, 王維濤, 徐平, 王衛(wèi)東. DynaCT 3D iGuide 穿刺技術(shù)在肺癌微波消融中的應(yīng)用. 中國胸心血管外科臨床雜志, 2023, 30(2): 221-225. doi: 10.7507/1007-4848.202102052
FAN Chen, TANG Haohuan, ZHOU Qi, SUN Feihu, DING Wei, SUN Lei, WANGWeitao, XU Ping, WANG Weidong. Application of DynaCT combined with 3D iGuidepuncture technique to microwave ablation of lung cancer. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2023, 30(2): 221-225. doi:10.7507/1007-4848.202102052
彭東閣, 孫偉. 肺轉(zhuǎn)移瘤外科治療的臨床效果及其預(yù)后相關(guān)危險因素的單中心隊列研究. 中國胸心血管外科臨床雜志, 2023, 30(1): 100-105. doi: 10.7507/1007-4848.202111005
PENG Dongge, SUN Wei. Clinical effect of surgical treatment for lungmetastasis and prognostic risk factor analysis: A single-center cohort study.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(1):100-105. doi: 10.7507/1007-4848.202111005
戢艷麗, 降初拉爾布, 王文憑, 胡楊, 馬林, 袁勇, 林鋒, 車國衛(wèi). 高原醫(yī)療中心開展高原地區(qū)患者胸外科手術(shù)的安全性分析. 中國胸心血管外科臨床雜志, 2023, 30(1): 95-99. doi: 10.7507/1007-4848.202111050
JI Yanli, JIANG Chulaerbu, WANG Wenping, HU Yang, MA Lin, YUAN Yong,LIN Feng, CHE Guowei. Safety and feasibility of thoracic surgery forhigh-altitude patients in the high-altitude medical center. Chinese Journal ofClinical Thoracic and Cardiovascular Surgery, 2023, 30(1): 95-99. doi:10.7507/1007-4848.202111050
陶紹霖, 戴富強, 梅龍勇, 馮涌耕, 方春抒, 吳禮成, 孫天宇, 郭偉, 鄧波, 譚群友. 機器人輔助解剖性肺基底段切除術(shù)臨床應(yīng)用的回顧性分析. 中國胸心血管外科臨床雜志, 2023, 30(1): 65-70. doi: 10.7507/1007-4848.202207020
TAO Shaolin, DAI Fuqiang, MEI Longyong, FENG Yonggeng, FANG Chunshu,WU Licheng, SUN Tianyu, GUO Wei, DENG Bo, TAN Qunyou. Application ofrobot-assisted lung basal segmentectomy: A retrospective study. Chinese Journalof Clinical Thoracic and Cardiovascular Surgery, 2023, 30(1): 65-70. doi:10.7507/1007-4848.202207020
詹必成, 劉建, 陳劍, 劉永志, 李根水, 郭昆亮, 王嘯, 熊焱正, 古明博. 胸腔鏡肺聯(lián)合亞段切除術(shù)76例的單中心回顧性研究. 中國胸心血管外科臨床雜志, 2023, 30(1): 47-51. doi: 10.7507/1007-4848.202207076
ZHAN Bicheng, LIU Jian, CHEN Jian, LIU Yongzhi, LI Genshui, GUOKunliang, WANG Xiao, XIONG Yanzheng, GU Mingbo. Thoracoscopic combinedsubsegmentectomy for 76 patients: A retrospective study in a single center.Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(1):47-51. doi: 10.7507/1007-4848.202207076